MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer with a poor prognosis, and effective treatments for PDAC are lacking. In this study, we hypothesized that miR-506 promotes antitumor immune response in PDAC by reprogramming tumor-associated macrophages toward an M1 phenotype to re...

Descrición completa

Detalles Bibliográficos

Principais autores:	Tiantian Yang, Yitong Han, Junhang Chen, Xiaoyu Liang, Longhao Sun
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-10-01
Series:	Biomedicines
Assuntos:	miR-506 pancreatic cancer reprogram signal transducer and activator of transcription 3 tumor-associated macrophage
Acceso en liña:	https://www.mdpi.com/2227-9059/11/11/2874
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!